Better Representation, Better Outcomes. Women in Clinical Trails
Topic : Inequalities Type : Graphic
Despite women making up over half of the population, women have historically been underrepresented in clinical trials, creating gaps in understanding how conditions present, progress and respond to treatment.
This infographic is informed by a recent discussion with Dr Nina Wilson, ABHI’s Clinical Advisor, and Bobbi Chapman MD, Vice President, Health Failure at Johnson & Johnson. Their conversation explored the real‑world impact of underrepresentation in clinical research, the practical and systemic barriers that continue to limit women’s participation, and the steps that stakeholders across the health and life sciences ecosystem can take to close this gap.
Key barriers highlighted include unintentional biases in time and cost pressures related to women’s lives, poor recruitment design, unconscious bias in clinical trial messaging and imagery, and limited representation of women in trial leadership. Most importantly, the webinar focused on steps that can be taken to improve representation of women in clinical trials from flexible visits and financial support to ease participation around childcare, to recruitment planning and demographic dashboards to improve awareness, reviewing trial marketing and fostering opportunities for women in trial leadership.
This infographic will support ABHI’s wider programme of engagement on women’s health, aiming to spotlight continued challenges in women’s health. Improving representation in clinical trials is a shared responsibility, and a critical step towards better research, better innovation and better outcomes for women.
